These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 17619349

  • 1. [Convincing results from the JIKEI Study].
    MMW Fortschr Med; 2006 Dec 14; 148(51-52):55. PubMed ID: 17619349
    [No Abstract] [Full Text] [Related]

  • 2. [Successful mega studies with heart patients. Valsartan possesses cardioprotective action].
    MMW Fortschr Med; 2006 Feb 02; 148(5):48-9. PubMed ID: 16518941
    [No Abstract] [Full Text] [Related]

  • 3. [Scientific evidence--applied in routine general practice. Successful decrease in pressure and risk].
    MMW Fortschr Med; 2006 May 04; 148(18):42-3. PubMed ID: 16736689
    [No Abstract] [Full Text] [Related]

  • 4. Two amlodipine/ARB combinations for hypertension.
    Med Lett Drugs Ther; 2007 Dec 17; 49(1276):101-2. PubMed ID: 18084152
    [No Abstract] [Full Text] [Related]

  • 5. Angiotensin receptor blockers: baseline therapy in hypertension?
    Messerli FH, Bangalore S, Ruschitzka F.
    Eur Heart J; 2009 Oct 17; 30(20):2427-30. PubMed ID: 19723696
    [No Abstract] [Full Text] [Related]

  • 6. Aliskiren/valsartan (Valturna) for hypertension.
    Med Lett Drugs Ther; 2009 Nov 30; 51(1326):94-5. PubMed ID: 20224524
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Angiotensin II type 1 receptor blockers and congestive heart failure.
    Auer JW, Berent R, Eber B.
    Circulation; 2001 Oct 09; 104(15):E82. PubMed ID: 11591633
    [No Abstract] [Full Text] [Related]

  • 9. [VALISH].
    Rakugi H, Ogihara T.
    Nihon Rinsho; 2006 Aug 09; 64 Suppl 6():454-8. PubMed ID: 16981579
    [No Abstract] [Full Text] [Related]

  • 10. The surge of Japanese studies supporting the use of angiotensin receptor blockers in hypertension.
    Kjeldsen SE, Narkiewicz K, Hedner T.
    Blood Press; 2009 Aug 09; 18(5):240-1. PubMed ID: 19919393
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of treatment benefit and outcome in women versus men with chronic heart failure (from the Valsartan Heart Failure Trial).
    Majahalme SK, Baruch L, Aknay N, Goedel-Meinen L, Hofmann M, Hester A, Prescott MF, Feliciano N, Val-HeFT Study Investigators.
    Am J Cardiol; 2005 Feb 15; 95(4):529-32. PubMed ID: 15695147
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [VALUE].
    Okura T, Higaki J.
    Nihon Rinsho; 2006 Aug 15; 64 Suppl 6():419-24. PubMed ID: 16981573
    [No Abstract] [Full Text] [Related]

  • 14. [Coronary stenting. Does AT-1 blocker protect from restenosis?].
    MMW Fortschr Med; 2003 Nov 13; 145(46):50. PubMed ID: 14712790
    [No Abstract] [Full Text] [Related]

  • 15. [ESC guidelines for therapy of heart failure. AT1 blockers are now also included].
    MMW Fortschr Med; 2002 Jan 24; 144(3-4):62. PubMed ID: 11862800
    [No Abstract] [Full Text] [Related]

  • 16. HEAAL: the final chapter in the story of angiotensin receptor blockers in heart failure--lessons learnt from a decade of trials.
    McMurray JJ, Swedberg K.
    Eur J Heart Fail; 2010 Feb 24; 12(2):99-103. PubMed ID: 20083618
    [No Abstract] [Full Text] [Related]

  • 17. Are angiotensin II receptor antagonists indicated in chronic heart failure?
    Komajda M.
    Heart Fail Monit; 2002 Feb 24; 2(3):85-7. PubMed ID: 12634889
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Concerns about the Jikei Heart Study.
    Yui Y.
    Lancet; 2012 Apr 14; 379(9824):e48. PubMed ID: 22500880
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.